Design Therapeutics Inc (DSGN)
EBITDA
-$22.03M
Quarterly · Period ending: · USD
DSGN EBITDA
Latest reported-$22.03Mperiod ending
Latest reported-$22.03Mperiod ending
DSGN Quarterly EBITDA (-$623.00K → -$22.03M)
Quarterly EBITDA
High-resolution chart · PNG
DSGN ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -22,026,000 | |
| -17,479,000 | |
| -15,841,000 | |
| -16,842,000 | |
| -18,931,000 | |
| -17,556,000 | |
| -13,502,000 | |
| -12,886,000 | |
| -11,642,000 | |
| -10,962,000 | |
| -11,704,000 | |
| -15,652,000 | |
| -19,804,000 | |
| -19,165,000 | |
| -17,216,000 | |
| -17,596,000 | |
| -14,907,000 | |
| -13,183,000 | |
| -10,983,000 | |
| -11,287,000 | |
| -7,624,000 | |
| -5,676,000 | |
| -3,857,000 | |
| -2,382,000 | |
| -1,463,000 | |
| -623,000 |